BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31333175)

  • 1. Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making.
    Anderson-Shaw LK
    AMA J Ethics; 2019 Jul; 21(7):E594-599. PubMed ID: 31333175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making Medical Treatment Decisions for Unrepresented Patients in the ICU. An Official American Thoracic Society/American Geriatrics Society Policy Statement.
    Pope TM; Bennett J; Carson SS; Cederquist L; Cohen AB; DeMartino ES; Godfrey DM; Goodman-Crews P; Kapp MB; Lo B; Magnus DC; Reinke LF; Shirley JL; Siegel MD; Stapleton RD; Sudore RL; Tarzian AJ; Thornton JD; Wicclair MR; Widera EW; White DB
    Am J Respir Crit Care Med; 2020 May; 201(10):1182-1192. PubMed ID: 32412853
    [No Abstract]   [Full Text] [Related]  

  • 3. Who Makes Decisions for Incapacitated Patients Who Have No Surrogate or Advance Directive?
    Schweikart SJ
    AMA J Ethics; 2019 Jul; 21(7):E587-593. PubMed ID: 31333174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment decisions for patients without surrogates: rethinking policies for a vulnerable population.
    Miller TE; Coleman CH; Cugliari AM
    J Am Geriatr Soc; 1997 Mar; 45(3):369-74. PubMed ID: 9063286
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethical Challenges in Caring for Unrepresented Adults: A Qualitative Study of Key Stakeholders.
    Verma A; Smith AK; Harrison KL; Chodos AH
    J Am Geriatr Soc; 2019 Aug; 67(8):1724-1729. PubMed ID: 31059129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five Things Clinicians Should Know When Caring for Unrepresented Patients.
    Pope TM
    AMA J Ethics; 2019 Jul; 21(7):E582-586. PubMed ID: 31333173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Should Clinicians Navigate Decision Making for Unrepresented Patients?
    Dempsey TM; DeMartino ES
    AMA J Ethics; 2019 Jul; 21(7):E559-565. PubMed ID: 31333170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of a Hospital Ethics Consultation Service in Decision-Making for Unrepresented Patients.
    Courtwright AM; Abrams J; Robinson EM
    J Bioeth Inq; 2017 Jun; 14(2):241-250. PubMed ID: 28265798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who Are "Unrepresented" Patients and What Count as "Important" Medical Decisions for Them?
    Ozar D
    AMA J Ethics; 2019 Jul; 21(7):E611-616. PubMed ID: 31333178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficult healthcare transitions: Ethical analysis and policy recommendations for unrepresented patients.
    Abdool R; Szego M; Buchman D; Justason L; Bean S; Heesters A; Kaufman H; Parke B; Wagner F; Gibson J
    Nurs Ethics; 2016 Nov; 23(7):770-783. PubMed ID: 26159620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surrogate decision-making legislation: the next frontier in life-sustaining treatment policy.
    Portman RM
    J Health Hosp Law; 1991 Oct; 24(10):311-9. PubMed ID: 10114557
    [No Abstract]   [Full Text] [Related]  

  • 12. Legal Briefing: Adult Orphans and the Unbefriended: Making Medical Decisions for Unrepresented Patients without Surrogates.
    Pope TM
    J Clin Ethics; 2015; 26(2):180-8. PubMed ID: 26132070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making Medical Decisions for Incapacitated Patients Without Proxies: Part II.
    Blackstone E; Daly BJ; Griggins C
    HEC Forum; 2020 Mar; 32(1):47-62. PubMed ID: 31691879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who Should Make Decisions for Unrepresented Patients Who Are Incarcerated?
    Tobey M; Simon L
    AMA J Ethics; 2019 Jul; 21(7):E617-624. PubMed ID: 31333179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care of Patients at the End of Life: Surrogate Decision Making for Incapacitated Patients.
    Patel AV; Ackermann RJ
    FP Essent; 2016 Aug; 447():32-41. PubMed ID: 27490071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Surrogates Decide: A Secondary Data Analysis of Decision-Making Principles Used by the Surrogates of Hospitalized Older Adults.
    Devnani R; Slaven JE; Bosslet GT; Montz K; Inger L; Burke ES; Torke AM
    J Gen Intern Med; 2017 Dec; 32(12):1285-1293. PubMed ID: 28840485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When others must choose: deciding for patients without capacity. The New York State Task Force on Life and the Law.
    Daly RW
    HEC Forum; 1993 Mar; 5(2):100-7. PubMed ID: 10125155
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical Decision Making for Unrepresented Patients: A Reflection on Colorado's Approach with Implications for Elsewhere.
    Furfari K
    J Clin Ethics; 2022; 33(4):297-302. PubMed ID: 36548233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public policy in the wake of Cruzan: a case study of New York's health care proxy law.
    Miller TE
    Law Med Health Care; 1990; 18(4):360-7. PubMed ID: 2089189
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal fundamentals of surrogate decision making.
    Pope TM
    Chest; 2012 Apr; 141(4):1074-1081. PubMed ID: 22474149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.